SC Clubul Sanatatii SRL
Campulung, Romania
Medical center in Câmpulung
Str. Bratianu I.C., 54B, Câmpulung, Arges, 115100, Câmpulung 115100
About SC Clubul Sanatatii SRL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Celgene
3
AB Science
1
Jazz Pharmaceuticals
1
Clinical Trials at SC Clubul Sanatatii SRL
During the past decade, SC Clubul Sanatatii SRL conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
2011-08-01
2020-02-01
Completed
656
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
2012-09-18
2016-05-11
Completed
258
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
2014-08-05
2022-01-31
Completed
95
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
2019-08-12
2028-04-04
Recruiting
1,000
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
2020-10-01
2023-02-27
Terminated
238
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "SC Clubul Sanatatii SRL"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at SC Clubul Sanatatii SRL
According to Clinical.Site data, the most researched conditions in "SC Clubul Sanatatii SRL" are
"Multiple Sclerosis, Primary Progressive" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Multiple Sclerosis, Relapse Free" (1 trials). Many other conditions were trialed in "SC Clubul Sanatatii SRL" in a lesser frequency.
Clinical Trials Intervention Types at SC Clubul Sanatatii SRL
Most popular intervention types in "SC Clubul Sanatatii SRL" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (2 trials), "Ozanimod" (2 trials), "Interferon beta-1a" (1 trials) and "Interferon beta-1a placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SC Clubul Sanatatii SRL
The vast majority of trials in "SC Clubul Sanatatii SRL" are
9 trials for "All" genders.
Clinical Trials Status at SC Clubul Sanatatii SRL
Currently, there are NaN active trials in "SC Clubul Sanatatii SRL".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in SC Clubul Sanatatii SRL,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SC Clubul Sanatatii SRL, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".